Cambridge Consultants’ And Chiesi Farmaceutici SpA’s Innovative Dry Powder Inhaler Nears Release

A new generation dry powder inhaler, NEXT™, whose aim is to help improve the treatment of asthma and COPD (chronic obstructive pulmonary disease) through greater user appeal and more efficient and consistent drug delivery, is to be presented for the first time at the Respiratory Drug Delivery (RDD) conference in Florida on April 23 – 27 2006.

MORE ON THIS TOPIC